Document is current

Any future updates will be listed below

Mdm2 targeting via PROteolysis TArgeting Chimeras (PROTAC) is efficient in p53 wildtype, p53-mutated, and abemaciclib-resistant estrogen receptor-positive cell lines and superior to mdm2 inhibition

Crossref DOI link: https://doi.org/10.1186/s12885-025-14361-z

Published Online: 2025-06-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark